• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Macquarie Group: Investment Portfolio & Startup News

Macquarie Group

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Foresight lands a £19m Series A led by Macquarie for predictive infrastructure delivery platformForesight lands a £19m Series A led by Macquarie for predictive infrastructure delivery platform
    Foresight
    19 Mar 2026

    Foresight lands a £19m Series A led by Macquarie for predictive infrastructure delivery platform

    Foresight is a project delivery platform for large-scale infrastructure programs. It provides visibility into project risk and progress to help asset owners and operators manage delivery and avoid delays.

    Bracket secures a £5m seed round led by Macquarie Group and Blackfinch Ventures for mid-market FX and treasury platformBracket secures a £5m seed round led by Macquarie Group and Blackfinch Ventures for mid-market FX and treasury platformBracket secures a £5m seed round led by Macquarie Group and Blackfinch Ventures for mid-market FX and treasury platform
    12 Feb 2026

    Bracket secures a £5m seed round led by Macquarie Group and Blackfinch Ventures for mid-market FX and treasury platform

    Bracket provides an FX and treasury management platform for mid-market companies. It centralises bank accounts and automates workflows to improve cash visibility and currency risk control.

Macquarie Group
    • Enterprise
    • Fintech
  • 2(12 months)
  • macquarie.com/uk/en.html

More venture news

  • Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
    Boltz
    18 Nov 2026

    Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design

    Series ALife Sciences
  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn